Constipation, polyps, or cancer? Let PTEN predict your future

Area of Science:

• Genetics and Molecular Biology
• Oncology
• Gastroenterology

Background:

• Inherited hamartoma polyposis syndromes include Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), juvenile polyposis syndrome (JPS), and Peutz-Jeghers syndrome (PJS).
• These syndromes have diverse genetic underpinnings, affecting different genes such as PTEN, MADH4, BMPR1A, and LKB1 (STK11).
• Clinical presentations and associated cancer risks vary significantly among these syndromes.

Purpose of the Study:

• To differentiate between inherited hamartoma polyposis syndromes based on their genetic mutations.
• To highlight the varying polyp characteristics and cancer risks associated with each syndrome.
• To emphasize the importance of molecular-based diagnosis for effective medical management.

Main Methods:

• Review of genetic mutations associated with CS, BRRS, JPS, and PJS.
• Analysis of clinical features, including polyp types and distribution.
• Correlation of specific gene mutations with cancer risks for each syndrome.

Main Results:

• PTEN mutations are linked to CS (80%) and BRRS (60%), with associated risks of breast, thyroid, and endometrial cancers.
• JPS is associated with MADH4 and BMPR1A mutations, increasing gastrointestinal cancer risk.
• PJS is linked to LKB1 (STK11) mutations, also associated with increased gastrointestinal cancer risk.
• Glycogenic acanthosis of the esophagus is a predictive marker for PTEN mutation-positive CS.

Conclusions:

• Distinguishing between these syndromes through molecular diagnostics is essential for personalized medical management.
• Understanding the specific genetic basis and associated cancer risks allows for targeted surveillance and early intervention.
• The study underscores the heterogeneity of hamartoma polyposis syndromes and the need for precise genetic identification.